Illustrating another instance of UBE2C and CDC20 co‐expression, Bruno S et al. explored Chronic Lymphocytic Leukemia (CLL), a hematological malignancy where CDC20 has been implicated in the high‐risk category. Here, UBE2C is linked to B-cell chronic lymphocytic leukemia.